PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEsmethadone
Esmethadone
Esmethadone is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
disketsNew Drug Application2023-12-01
diskets dispersible2007-08-03
methadone2007-10-06
methadone hcl2008-05-08
methadone hydrochlorideANDA2025-09-09
methadone hydrochloride methadose2006-09-19
methadone hydrochloride methadose dispersibleANDA2024-06-28
methadone hydroclorideANDA2025-05-29
methadoseNew Drug Application2024-07-24
methadose methadoseNew Drug Application2011-01-28
Show 1 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
37 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Opioid-related disordersD009293EFO_0005611F112248
NeuralgiaD009437EFO_0009430213
Heroin dependenceD006556EFO_000424011
Free tissue flapsD05875211
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic painD0593501112
Restless legs syndromeD012148EFO_0004270G25.8111
Psychomotor agitationD01159511
SyndromeD01357711
Treatment-resistant depressive disorderD06121811
Prostatic neoplasmsD011471C61111
Breast neoplasmsD001943EFO_0003869C50111
Pancreatic neoplasmsD010190EFO_0003860C25111
Head and neck neoplasmsD006258111
Esophageal neoplasmsD004938C15111
Show 7 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis cD006526B19.222
Healthy volunteers/patients22
Chronic hepatitis cD019698EFO_0004220B18.211
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Substance-related disordersD019966EFO_0003890F1322
Drug-related side effects and adverse reactionsD064420T88.711
Low back painD017116M54.511
Intractable painD01014811
Hiv seropositivityD00667911
Cocaine-related disordersD019970F1411
Sleep wake disordersD012893G4711
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEsmethadone
INNesmethadone
Description
Dextromethadone is a 6-(dimethylamino)-4,4-diphenylheptan-3-one that has (S)-configuration. It is the less active enantiomer of methadone and has very little activity on opioid receptors and mainly responsible for the inhibition of hERG K+ channels and thus for cardiac toxicity. The drug is currently under clinical development for the treatment of major depressive disorder. It has a role as a NMDA receptor antagonist and an opioid analgesic. It is an enantiomer of a levomethadone.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCC(=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1
Identifiers
PDB
CAS-ID5653-80-5
RxCUI
ChEMBL IDCHEMBL350719
ChEBI ID
PubChem CID643985
DrugBankDB15198
UNII IDS95RZH8AMH (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 41,387 documents
View more details
Safety
Black-box Warning
Black-box warning for: Diskets, Methadone, Methadone hydrochloride, Methadone hydrochloride methadose, Methadone hydrochloride methadose dispersible, Methadone hydrocloride, Methadose, Methadose methadose, Methadose methadose sugar-free
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use